查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1455673

裂谷热疫苗市场，按产品类型、按应用、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Rift Valley Fever Vaccines Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年，裂谷热疫苗市场规模为 2.1045 亿美元，2024 年至 2032 年复合CAGR为 6.2%。

裂谷热疫苗市场-市场动态

透过公共卫生教育以及社会和医疗环境的进步提高意识，以推动市场需求

由于公共卫生教育的提高以及社会和医疗环境的进步，裂谷热疫苗市场正在经历显着增长。技术进步使卫生和动物专业人员能够有效地为人类和动物接种疫苗，进一步推动市场扩张。裂谷热疫苗的驱动因素包括裂谷热疫情的日益流行，特别是在流行地区，这加剧了采取有效预防措施的迫切性。此外，政府、医疗机构和农业部门对裂谷热对经济和公共卫生影响的认识不断提高，凸显了疫苗接种作为疾病控制的主动方法的重要性。此外，疫苗技术和研究的进步，加上产业利益相关者和监管机构之间的合作努力，有助于裂谷热疫苗的开发和可及性。这些驱动因素共同强调了疫苗接种在缓解裂谷热传播并降低相关发病率和死亡率方面的关键作用。然而，儘管有这些积极因素，但对潜在不良反应的担忧可能会阻碍市场成长。

裂谷热疫苗市场 - 主要见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 6.2% 左右的CAGR成长

根据产品类型细分，预计活疫苗将在 2023 年占据最大市场份额

从应用细分来看，2023年牛是主导类型

按地区划分，北美是 2023 年的主要收入来源

裂谷热疫苗市场-細項分析：

全球裂谷热疫苗市场根据产品类型、应用和地区进行细分。

根据产品类型，市场分为两类：灭活的和活的。在裂谷热疫苗市场中，活疫苗由于能够引发强烈而持久的免疫反应，因此在该类型细分市场中占据主导地位。这些疫苗含有裂谷热病毒的弱化或减毒版本，反映了自然感染而不诱发疾病。这会引发强烈的免疫反应，产生抗体和记忆细胞，从而提供对未来感染的保护。活疫苗因其功效和赋予各种动物物种和种群广泛免疫力的潜力而受到重视，使其成为裂谷热疫苗接种计划的首选。

市场依应用分为五类：牛、山羊、人、绵羊和其他。在应用方面，到2023年，牛隻将成为裂谷热疫苗市场的主导部门。牛极易感染裂谷热病毒，牲畜之间的疫情爆发可能会对农民和农业部门带来重大的经济影响。为牛接种裂谷热疫苗有助于防止疾病传播、降低发病率和死亡率并保障农民的生计。此外，保护牛隻免受裂谷热的侵害对于维护粮食安全和避免人畜共患病传播给人类至关重要，这突显了针对这一关键动物群体的疫苗接种工作的重要性。

裂谷热疫苗市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。

裂谷热疫苗市场-竞争格局：

在裂谷热疫苗市场，该公司正在实施多种策略，以推动有效且易于使用的疫苗的开发。这些策略包括持续研究，旨在增强疫苗配方、改善给药方案和提高疫苗稳定性，以方便储存和运输，特别是在资源有限的环境中。此外，公司正在与政府、国际组织和研究机构合作，以简化疫苗开发、监管批准和分销流程。此外，正在进行教育活动，以提高农民、兽医和医护人员对疫苗接种在控制裂谷热疫情和保护动物和人类健康方面重要性的认识。

最近的发展：

2023 年 4 月，报告了一项重大进展：启动了一项 1 期临床试验，评估 ChAdOx1 疫苗在英国成人中治疗裂谷热的安全性。这项非随机开放标籤试验是对抗裂谷热旅程中的一个重要里程碑，并强调了开发针对这种病毒性疾病的有效疫苗的持续努力。

目录

第一章：裂谷热疫苗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的裂谷热疫苗市场片段
    • 裂谷热疫苗市场片段（依应用）
    • 按国家分類的裂谷热疫苗市场片段
    • 按地区分類的裂谷热疫苗市场片段
  • 竞争洞察

第 3 章：裂谷热疫苗主要市场趋势

  • 裂谷热疫苗市场驱动因素
    • 市场驱动因素的影响分析
  • 裂谷热疫苗市场限制
    • 市场限制影响分析
  • 裂谷热疫苗市场机会
  • 裂谷热疫苗市场未来趋势

第 4 章：裂谷热疫苗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：裂谷热疫苗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：裂谷热疫苗市场格局

  • 2023 年裂谷热疫苗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：裂谷热疫苗市场 - 依产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 灭活
    • 居住

第 8 章：裂谷热疫苗市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 牛
    • 山羊
    • 人们
    • 羊
    • 其他

第 9 章：裂谷热疫苗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美裂谷热疫苗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲裂谷热疫苗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按应用）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区裂谷热疫苗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按应用）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲裂谷热疫苗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲裂谷热疫苗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 10 章：主要供应商分析 - 裂谷热疫苗产业

  • 竞争仪表板
  • 公司简介
    • Veterinary Serum and Vaccine Research Institute
    • Medgene Labs
    • VSVRI
    • Onderstepoort Biological Products
    • OBP
    • Others

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2336

REPORT HIGHLIGHT

Rift Valley Fever Vaccines Market size was valued at USD 210.45 Million in 2023, expanding at a CAGR of 6.2% from 2024 to 2032.

Rift Valley Fever is a viral illness transmitted through mosquito bites, affecting both humans and animals. The virus spreads through direct contact with infected animal blood and tissues, as well as mosquito bites. While the virus often presents without symptoms, it can lead to serious complications such as encephalitis, blindness, and hemorrhagic fever. Rift Valley Fever vaccines come in two forms: live attenuated RVF vaccine (Smithburn strain) and killed vaccine. Vaccination protects both humans and animals, crucial for food security and economic stability. These vaccines are essential in preventing the spread of this zoonotic disease, playing a significant role in livestock management and public health initiatives, particularly in endemic areas where RVF outbreaks pose substantial risks.

Rift Valley Fever Vaccines Market- Market Dynamics

Increasing awareness through public health education and advancements in social and medical landscapes to propel market demand

The Rift Valley Fever Vaccines Market is experiencing significant growth due to heightened awareness through public health education and advancements in social and medical landscapes. Technological progress enables health and animal professionals to efficiently vaccinate both humans and animals, further driving market expansion. The drivers of Rift Valley Fever vaccines include the increasing prevalence of Rift Valley Fever outbreaks, particularly in endemic regions, which heightens the urgency for effective preventive measures. Additionally, the rising awareness among governments, healthcare organizations, and agricultural sectors about the economic and public health impacts of Rift Valley Fever underscores the importance of vaccination as a proactive approach to disease control. Furthermore, advancements in vaccine technology and research, coupled with collaborative efforts between industry stakeholders and regulatory bodies, contribute to the development and accessibility of Rift Valley Fever vaccines. These drivers collectively emphasize the critical role of vaccination in mitigating the spread of Rift Valley Fever and reducing its associated morbidity and mortality rates. However, concerns regarding potential adverse reactions may impede market growth despite these positive factors.

Rift Valley Fever Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.2% over the forecast period (2024-2032)

Based on product type segmentation, Live vaccines was predicted to show maximum market share in the year 2023

Based on Application segmentation, Cattle was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Rift Valley Fever Vaccines Market- Segmentation Analysis:

The Global Rift Valley Fever Vaccines Market is segmented on the basis of Product Type, Application, and Region.

The market is divided into two categories based on product type: Inactivated and Live. Within the Rift Valley Fever vaccine market, live vaccines take precedence in the type segment due to their capacity to elicit robust and enduring immune responses. These vaccines contain weakened or attenuated versions of the Rift Valley Fever virus, mirroring natural infection without inducing illness. This prompts a vigorous immune reaction, generating antibodies and memory cells that confer protection against future infections. Live vaccines are valued for their efficacy and potential to confer broad immunity across various animal species and populations, making them the preferred option for Rift Valley Fever vaccination initiatives.

The market is divided into five categories based on Application: Cattle, Goats, People, Sheep and Other. Regarding application, in 2023, the cattle segment emerges as the dominant sector in the Rift Valley Fever vaccine market. Cattle are highly vulnerable to Rift Valley Fever virus infection, and outbreaks among livestock can carry significant economic repercussions for farmers and the agricultural sector. Vaccinating cattle against Rift Valley Fever helps prevent disease spread, diminish morbidity and mortality rates, and safeguard farmers' livelihoods. Additionally, shielding cattle from Rift Valley Fever is crucial for upholding food security and averting zoonotic transmission to humans, highlighting the significance of vaccination endeavors targeting this pivotal animal demographic.

Rift Valley Fever Vaccines Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Rift Valley Fever Vaccines Market- Competitive Landscape:

In the Rift Valley Fever vaccine market, companies are implementing diverse strategies to advance the development of effective and accessible vaccines. These strategies encompass continuous research aimed at enhancing vaccine formulations, refining dosing regimens, and improving vaccine stability to facilitate easier storage and transportation, particularly in resource-constrained environments. Moreover, companies are engaging in collaborations with governments, international organizations, and research institutions to streamline vaccine development, regulatory approval, and distribution processes. Additionally, educational campaigns are being conducted to raise awareness among farmers, veterinarians, and healthcare workers regarding the importance of vaccination in controlling Rift Valley Fever outbreaks and protecting both animal and human health.

Recent Developments:

In April 2023, a significant development was reported: the initiation of a phase 1 clinical trial assessing the safety of a ChAdOx1 vaccine regarding Rift Valley Fever in UK adults. This non-randomized open-label, trial represents a critical milestone in the journey toward combating Rift Valley Fever and underscores the ongoing efforts to develop effective vaccines against this viral illness.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RIFT VALLEY FEVER VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Veterinary Serum and Vaccine Research Institute

Medgene Labs

VSVRI

Onderstepoort Biological Products

OBP

Others

GLOBAL RIFT VALLEY FEVER VACCINES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Inactivated
  • Live

GLOBAL RIFT VALLEY FEVER VACCINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cattle
  • Goats
  • People
  • Sheep
  • Other

GLOBAL RIFT VALLEY FEVER VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Rift Valley Fever Vaccines Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Rift Valley Fever Vaccines Market Snippet by Product Type
    • 2.1.2.Rift Valley Fever Vaccines Market Snippet by Application
    • 2.1.3.Rift Valley Fever Vaccines Market Snippet by Country
    • 2.1.4.Rift Valley Fever Vaccines Market Snippet by Region
  • 2.2.Competitive Insights

3.Rift Valley Fever Vaccines Key Market Trends

  • 3.1.Rift Valley Fever Vaccines Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Rift Valley Fever Vaccines Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Rift Valley Fever Vaccines Market Opportunities
  • 3.4.Rift Valley Fever Vaccines Market Future Trends

4.Rift Valley Fever Vaccines Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Rift Valley Fever Vaccines Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Rift Valley Fever Vaccines Market Landscape

  • 6.1.Rift Valley Fever Vaccines Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Rift Valley Fever Vaccines Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Inactivated
    • 7.1.3.Live

8.Rift Valley Fever Vaccines Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Cattle
    • 8.1.3.Goats
    • 8.1.4.People
    • 8.1.5.Sheep
    • 8.1.6.Other

9.Rift Valley Fever Vaccines Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Rift Valley Fever Vaccines Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Rift Valley Fever Vaccines Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Rift Valley Fever Vaccines Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Rift Valley Fever Vaccines Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Rift Valley Fever Vaccines Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Rift Valley Fever Vaccines Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.Veterinary Serum and Vaccine Research Institute
    • 10.2.2.Medgene Labs
    • 10.2.3.VSVRI
    • 10.2.4.Onderstepoort Biological Products
    • 10.2.5.OBP
    • 10.2.6.Others

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Rift Valley Fever Vaccines Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Rift Valley Fever Vaccines Market, by Product Type 2019-2032 (USD Million)
  • TABLE Rift Valley Fever Vaccines Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Rift Valley Fever Vaccines Market, by Application 2019-2032 (USD Million)
  • TABLE Rift Valley Fever Vaccines Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Rift Valley Fever Vaccines Market, by Region 2019-2032 (USD Million)
  • TABLE North America Rift Valley Fever Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Rift Valley Fever Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Rift Valley Fever Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Rift Valley Fever Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Rift Valley Fever Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Rift Valley Fever Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rift Valley Fever Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rift Valley Fever Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rift Valley Fever Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Rift Valley Fever Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Rift Valley Fever Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Rift Valley Fever Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rift Valley Fever Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rift Valley Fever Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rift Valley Fever Vaccines Market, by Application, 2019-2032 (USD Million)

List of Figures

  • FIGURE Rift Valley Fever Vaccines Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Rift Valley Fever Vaccines Market share and leading players, 2023
  • FIGURE Europe Rift Valley Fever Vaccines Market share and leading players, 2023
  • FIGURE Asia Pacific Rift Valley Fever Vaccines Market share and leading players, 2023
  • FIGURE Latin America Rift Valley Fever Vaccines Market share and leading players, 2023
  • FIGURE Middle East and Africa Rift Valley Fever Vaccines Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Rift Valley Fever Vaccines Market share analysis by country, 2023
  • FIGURE Germany Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Rift Valley Fever Vaccines Market share analysis by country, 2023
  • FIGURE India Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Rift Valley Fever Vaccines Market share analysis by country, 2023
  • FIGURE Brazil Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Rift Valley Fever Vaccines Market share analysis by country, 2023
  • FIGURE Saudi Arabia Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)